CHRISTINE BENIGAR: Open Payments
NPI 1427043330 · KNIGHTDALE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,071 in 89 payments from 17 companies in 2025. Trend: 2023 $2,143 · 2024 $2,190 · 2025 $2,071
Food & beverage: $2,071
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $242 |
| Amgen Inc. | 5 | $241 |
| Regeneron Healthcare Solutions, Inc. | 8 | $225 |
| GENZYME CORPORATION | 6 | $199 |
| UCB, Inc. | 6 | $181 |
| Janssen Biotech, Inc. | 9 | $172 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $172 |
| E.R. Squibb & Sons, L.L.C. | 13 | $139 |
| Novartis Pharmaceuticals Corporation | 5 | $110 |
| Galderma Laboratories, L.P. | 5 | $94 |
Products named: DUPIXENT, Bimzelx, TREMFYA, RINVOQ, Sotyktu, OTEZLA, SKYRIZI, EBGLYSS.
Industry payments across NC — which companies pay providers there.
